CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients.

Lima, M V; Ribeiro, G S; Mesquita, E T; Victer, P R; Vianna-Jorge, R

Lima, M V; Ribeiro, G S; Mesquita, E T; Victer, P R; Vianna-Jorge, R.

Affiliation

Lima MV; Departamento de Medicina Clínica, Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Rio de Janeiro, Brazil.

Eur J Clin Pharmacol ; 64(1): 9-15, 2008 Jan.

Article de En | MEDLINE | ID: mdl-17955230

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Warfarine / Aryl hydrocarbon hydroxylases / Anticoagulants Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do sul / Brasil Langue: En Journal: Eur J Clin Pharmacol Année: 2008 Type de document: Article Pays d'affiliation: Brésil Pays de publication: Allemagne

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links